Improving the treatment of high-risk acute leukaemia

改善高危急性白血病的治疗

• 批准号: nhmrc : GNT1059804
• 负责人: Prof Richard Lock
• 金额: $ 60.14万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-treatment-high-acute-leukaemia/1344708
• 关键词: Improving; treatment; risk; acute; leukaemia

Recent research has focussed on molecular characterisation of high-risk acute leukaemia subtypes. This proposal will combine the power of genomic analysis, global analysis of protein kinases and stringent preclinical drug testing in order to improve the treatment of these high-risk acute leukaemia subtypes. Several innovative and interrelated projects within this Program will utilise a unique and clinically relevant experimental model to achieve their goals.

最近的研究集中在高危急性白血病亚型的分子特征。该提案将联合收割机结合基因组分析、蛋白激酶全球分析和严格的临床前药物测试的力量，以改善这些高危急性白血病亚型的治疗。该计划中的几个创新和相互关联的项目将利用独特的临床相关实验模型来实现其目标。